{"id":64079,"date":"2020-09-10T19:03:00","date_gmt":"2020-09-10T16:03:00","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/astrazeneca-covid-19-vaccine-could-be-ready-this-year-despite-study-halt\/"},"modified":"2020-09-10T19:03:00","modified_gmt":"2020-09-10T16:03:00","slug":"astrazeneca-covid-19-vaccine-could-be-ready-this-year-despite-study-halt","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/astrazeneca-covid-19-vaccine-could-be-ready-this-year-despite-study-halt\/","title":{"rendered":"#AstraZeneca COVID-19 vaccine could be ready this year despite study halt"},"content":{"rendered":"

“#AstraZeneca COVID-19 vaccine could be ready this year despite study halt<\/strong>”<\/p>\n

\n
\n
\n

September 10, 2020 |<\/span> 12:03pm |<\/span> Updated September 10, 2020 | 12:05pm<\/span><\/p>\n

\n AstraZeneca\u2019s coronavirus vaccine could still be ready this year even though it had to halt a key clinical study after a participant got sick, CEO Pascal Soriot said Thursday.<\/p>\n

The British pharmaceutical firm should know by the end of 2020 whether the vaccine protects patients from the virus if it\u2019s able to resume the study soon, Soriot said during an online event.<\/p>\n

\u201cWe could still have a vaccine by the end of this year, early next year,\u201d Soriot told reporters during the conference, according to The Wall Street Journal.<\/p>\n

AstraZeneca said Wednesday that it paused the so-called Phase 3 trial to review the participant\u2019s \u201cunexplained illness.\u201d An independent safety committee will determine whether the research can restart after it learns the person\u2019s diagnosis, which AstraZeneca has yet to confirm, according to Soriot.<\/p>\n

\u201cIt\u2019s very common, actually, and many experts will tell you this,\u201d Soriot said. \u201cThe difference with other vaccine trials is, the whole world is not watching them, of course. They stop, they study and they restart.\u201d<\/p>\n

Reports emerged that the woman had come down with a rare neurological condition called transverse myelitis, but AstraZeneca issued a statement saying there was no final diagnosis.<\/p>\n

AstraZeneca\u2019s vaccine, developed with the University of Oxford, is one of the leading candidates that could help bring an end to the global COVID-19 pandemic.<\/p>\n

Phase 3 studies \u2014 which aim to determine whether a vaccine is safe and effective \u2014 have also started for a potential vaccine from biotech firm Moderna and a joint effort between Pfizer and BioNTech.<\/p>\n

AstraZeneca was one of nine drugmakers that signed a joint statement Tuesday pledging to make safety their top priority as they race to develop a vaccine.<\/p>\n

AstraZeneca\u2019s US-listed shares were up 0.3 percent at $53.80 as of 11:51 a.m. Thursday.<\/p>\n

With Post wires<\/em>\n <\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n

\n

If you want to read more Business News<\/a> articles, you can visit our General category.<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n

\n

if you want to watch Movies<\/a> or Tv Shows go to Dizi.BuradaBiliyorum.Com<\/a> <\/span> for forums sites go to Forum.BuradaBiliyorum.Com<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n

Source<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

“#AstraZeneca COVID-19 vaccine could be ready this year despite study halt” September 10, 2020 | 12:03pm | Updated September 10, 2020 | 12:05pm AstraZeneca\u2019s coronavirus vaccine could still be ready this year even though it had to halt a key clinical study after a participant got sick, CEO Pascal Soriot said Thursday. The British pharmaceutical…<\/p>\n","protected":false},"author":1,"featured_media":64080,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"","fifu_image_alt":"","footnotes":""},"categories":[1],"tags":[67225],"class_list":["post-64079","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","tag-astrazeneca-covid-19-vaccine-could-be-ready-this-year-despite-study-halt"],"_links":{"self":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/64079","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/comments?post=64079"}],"version-history":[{"count":0,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/64079\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media\/64080"}],"wp:attachment":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media?parent=64079"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/categories?post=64079"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/tags?post=64079"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}